Literature DB >> 19049333

Mineralization and bone resorption are regulated by the androgen receptor in male mice.

Cherie Chiang1, Maria Chiu, Alison J Moore, Paul H Anderson, Ali Ghasem-Zadeh, Julie F McManus, Cathy Ma, Ego Seeman, Thomas L Clemens, Howard A Morris, Jeffrey D Zajac, Rachel A Davey.   

Abstract

Androgens play a key role in skeletal growth and bone maintenance; however, their mechanism of action remains unclear. To address this, we selectively deleted the androgen receptor (AR) in terminally differentiated, mineralizing osteoblasts using the Cre/loxP system in mice (osteocalcin-Cre AR knockouts [mOBL-ARKOs]). Male mOBL-ARKOs had decreased femoral trabecular bone volume compared with littermate controls because of a reduction in trabecular number at 6, 12, and 24 wk of age, indicative of increased bone resorption. The effects of AR inactivation in mineralizing osteoblasts was most marked in the young mutant mice at 6 wk of age when rates of bone turnover are high, with a 35% reduction in trabecular bone volume, decreased cortical thickness, and abnormalities in the mineralization of bone matrix, characterized by increased unmineralized bone matrix and a decrease in the amount of mineralizing surface. This impairment in bone architecture in the mOBL-ARKOs persisted throughout adulthood despite an unexpected compensatory increase in osteoblast activity. Our findings show that androgens act through the AR in mineralizing osteoblasts to maintain bone by regulating bone resorption and the coordination of bone matrix synthesis and mineralization, and that this action is most important during times of bone accrual and high rates of bone remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19049333     DOI: 10.1359/jbmr.081217

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  40 in total

1.  Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual.

Authors:  Rachel A Davey; Michele V Clarke; Stephen Sastra; Jarrod P Skinner; Cherie Chiang; Paul H Anderson; Jeffrey D Zajac
Journal:  Transgenic Res       Date:  2011-12-13       Impact factor: 2.788

Review 2.  Regulation of Bone Metabolism by Sex Steroids.

Authors:  Sundeep Khosla; David G Monroe
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

3.  The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We've Come, How Much Further We Need to Go.

Authors:  Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2018-02-22       Impact factor: 6.741

Review 4.  A look behind the scenes: the risk and pathogenesis of primary osteoporosis.

Authors:  Gretl Hendrickx; Eveline Boudin; Wim Van Hul
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

Review 5.  Androgen Receptor Structure, Function and Biology: From Bench to Bedside.

Authors:  Rachel A Davey; Mathis Grossmann
Journal:  Clin Biochem Rev       Date:  2016-02

Review 6.  Minireview: nuclear receptor regulation of osteoclast and bone remodeling.

Authors:  Zixue Jin; Xiaoxiao Li; Yihong Wan
Journal:  Mol Endocrinol       Date:  2014-12-30

Review 7.  Regulation of adult bone turnover by sex steroids.

Authors:  Baruch Frenkel; Albert Hong; Sanjeev K Baniwal; Gerhard A Coetzee; Claes Ohlsson; Omar Khalid; Yankel Gabet
Journal:  J Cell Physiol       Date:  2010-08       Impact factor: 6.384

8.  Sex-Dependent, Osteoblast Stage-Specific Effects of Progesterone Receptor on Bone Acquisition.

Authors:  Zhendong A Zhong; Alexander Kot; Yu-An E Lay; Hongliang Zhang; Junjing Jia; Nancy E Lane; Wei Yao
Journal:  J Bone Miner Res       Date:  2017-07-13       Impact factor: 6.741

Review 9.  The role of estrogen and androgen receptors in bone health and disease.

Authors:  Stavros C Manolagas; Charles A O'Brien; Maria Almeida
Journal:  Nat Rev Endocrinol       Date:  2013-09-17       Impact factor: 43.330

Review 10.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.